Sarcoma, Ewing
Showing 51 - 75 of 1,326
Osteosarcoma, Ewing Sarcoma, Rhabdomyosarcoma Trial in Washington (Cryoablation Therapy, Nivolumab, Ipilimumab)
Recruiting
- Osteosarcoma
- +9 more
- Cryoablation Therapy
- +2 more
-
Washington, District of ColumbiaChildren's National Hospital
Mar 21, 2022
Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Boston (Stereotactic Body Radiotherapy (SBRT))
Terminated
- Ewing Sarcoma
- +10 more
- Stereotactic Body Radiotherapy (SBRT)
-
Boston, Massachusetts
- +2 more
Apr 5, 2021
Sarcoma, Ewing, Tumor Metastasis Trial in Worldwide (Abemaciclib, Irinotecan, Temozolomide)
Not yet recruiting
- Sarcoma, Ewing
- Neoplasm Metastasis
- Abemaciclib
- +2 more
-
Phoenix, Arizona
- +29 more
Aug 17, 2022
Observational Study on Skeletal Ewing's Sarcoma
Recruiting
- Ewing Sarcoma of Bone
- Treatment of Ewings Sarcoma of bone according clinical practice (includes drugs, surgery, radiotherapy or any other received treatments)
-
Rozzano, MI, Italy
- +16 more
Oct 29, 2021
Late Effects, Testicular Germ Cell Tumor Mixed, Non-Metastatic Breast Carcinoma Trial in Lyon (PASCA intervention)
Recruiting
- Late Effects
- +8 more
- PASCA intervention
-
Lyon, FranceCentre Leon Berard
Mar 15, 2022
Lymphoma, Childhood Lymphoma, Solid Tumor Trial in Charlottesville (Genistein, Placebo)
Terminated
- Lymphoma
- +15 more
- Genistein
- Placebo
-
Charlottesville, VirginiaUniversity of Virginia
Feb 8, 2022
Ewing's Sarcoma, Primitive Neuroectodermal Tumor (PNET), Askin's Tumor of the Chest Wall Trial in France, Italy, United States
Completed
- Ewing's Sarcoma
- +3 more
-
Santa Monica, California
- +6 more
Sep 30, 2021
Ewing's Sarcoma Trial in Italy (Standard treatment (as per protocol ISG SSG III), Intensified chemo)
Active, not recruiting
- Ewing's Sarcoma
- Standard treatment (as per protocol ISG SSG III)
- Intensified chemotherapy
-
Aviano, Pordenone, Italy
- +13 more
Oct 29, 2021
Glioma, Neuroectodermal Tumors, Primitive, Wilms Tumor Trial in Saint Louis (Metronomic Cyclophosphamide, Thalidomide)
Recruiting
- Glioma
- +6 more
- Metronomic Cyclophosphamide
- Thalidomide
-
Saint Louis, MissouriWashington University School of Medicine
Sep 22, 2021
Breast Cancer Female, Acute Leukemia, Lymphoma Trial in Sweden (Triptorelin Embonate, Sodium Chloride solution 0.9%)
Not yet recruiting
- Breast Cancer Female
- +5 more
- Triptorelin Embonate
- Sodium Chloride solution 0.9%
-
Göteborg, Sweden
- +16 more
Oct 26, 2022
Adults Treated During Childhood or Adolescence for a Malignant Bone Tumor (Osteosarcoma and Ewing Sarcoma) Trial in Villejuif
Recruiting
- Adults Treated During Childhood or Adolescence for a Malignant Bone Tumor (Osteosarcoma and Ewing Sarcoma)
- MRI
-
Villejuif, FranceGustave Roussy
Sep 27, 2021
Clear Cell Sarcoma Trial in El Segundo, Houston (AMG 337)
Terminated
- Clear Cell Sarcoma
- AMG 337
-
El Segundo, California
- +1 more
Dec 9, 2022
Relapsed Pediatric Solid Tumors, Refractory Pediatric Solid Tumors, Rhabdomyosarcoma Trial in Washington, Cincinnati (Magnetic
Active, not recruiting
- Relapsed Pediatric Solid Tumors
- +9 more
- Magnetic Resonance High Intensity Focused Ultrasound
-
Washington, District of Columbia
- +1 more
Jan 21, 2022
Pediatric Cancer, Solid Tumors, Rhabdomyosarcoma Trial in Washington (Magnetic resonance high intensity focused ultrasound,
Recruiting
- Pediatric Cancer
- +9 more
- Magnetic resonance high intensity focused ultrasound
- Lyso-thermosensitive liposomal doxorubicin
-
Washington, District of ColumbiaChildren's National Medical Center
Dec 10, 2021
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma Trial in Madison (TCRaß+/CD19+ depleted Haploidentical
Recruiting
- Acute Myeloid Leukemia
- +10 more
- TCRαβ+/CD19+ depleted Haploidentical HSCT
- Zoledronate
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Mar 1, 2022
Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)
Completed
- Ependymoma
- +9 more
- Nivolumab
- NKTR-214
-
Little Rock, Arkansas
- +17 more
Dec 8, 2022
Advanced MR Imaging in Sarcoma Patients
Completed
- Sarcoma
-
Rochester, MinnesotaMayo Clinic
Feb 11, 2022
Recurrent or Refractory Solid Tumors, Ewing Sarcoma, Rhabdomyosarcoma Trial in United States (MM-398 (Irinotecan Sucrosofate
Recruiting
- Recurrent or Refractory Solid Tumors
- +4 more
- MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide
-
Cincinnati, Ohio
- +5 more
Mar 17, 2022
Osteosarcoma, Ewing Sarcoma Trial in Bologna (Metformin Hydrochloride)
Recruiting
- Osteosarcoma
- Ewing Sarcoma
- Metformin Hydrochloride
-
Bologna, ItalyChemotherapy Div, Istituto Ortopedico Rizzoli
Mar 28, 2021
Relapsed/Refractory Rhabdomyosarcoma, Non-rhabdomyosarcoma Soft Tissue Sarcoma, Ewing Sarcoma Trial in United States (Eribulin
Completed
- Relapsed/Refractory Rhabdomyosarcoma
- +2 more
- Eribulin mesylate
-
Birmingham, Alabama
- +40 more
Mar 18, 2022
Relapsed Neuroblastoma, Refractory Neuroblastoma, Relapsed Osteosarcoma Trial in Houston (C7R-GD2.CART cells, Cyclophosphamide,
Recruiting
- Relapsed Neuroblastoma
- +6 more
- C7R-GD2.CART cells
- +2 more
-
Houston, Texas
- +1 more
Nov 12, 2021